Evidence map›Paper›PMID 32670183›Full record

ArticleFrontiers in neurology2020

Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia.

Jean-Baptiste Oudart, Zoubir Djerada, Vignon Nonnonhou, Sarah Badr, Laurie-Anne Bertholon, Anis Dammak, Yacine Jaidi, Jean-Luc Novella, Nicolas Pallet, Philippe Gillery and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean-Baptiste OudartLaboratory of Biochemistry and Molecular Biology, Faculty of Medicine, University of Reims Champagne-Ardenne, SFR CAP-Santé (FED 4231), Reims, France.
Zoubir DjeradaLaboratory of Biochemistry, Pharmacology and Toxicology, Reims University Hospital, Reims, France.
Vignon NonnonhouChampagne-Ardenne Resource and Research Memory Center (CMRR), Maison Blanche Hospital, Reims University Hospital, Reims, France.
Sarah BadrDepartment of Internal Medicine and Geriatrics, Maison Blanche Hospital, Reims University Hospital, Reims, France.
Laurie-Anne BertholonDepartment of Internal Medicine and Geriatrics, Maison Blanche Hospital, Reims University Hospital, Reims, France.
Anis DammakDepartment of Psychiatry, Public Institution of Mental Health Marne, Châlons-en-Champagne Cedex, France.
Yacine JaidiDepartment of Internal Medicine and Geriatrics, Maison Blanche Hospital, Reims University Hospital, Reims, France.
Jean-Luc NovellaChampagne-Ardenne Resource and Research Memory Center (CMRR), Maison Blanche Hospital, Reims University Hospital, Reims, France.
Nicolas PalletDepartment of Biochemistry, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Philippe GilleryLaboratory of Biochemistry and Molecular Biology, Faculty of Medicine, University of Reims Champagne-Ardenne, SFR CAP-Santé (FED 4231), Reims, France.
Rachid MahmoudiChampagne-Ardenne Resource and Research Memory Center (CMRR), Maison Blanche Hospital, Reims University Hospital, Reims, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer diseaseamyloid peptideCSF biomarkerscut-off valuesdiagnostic algorithm

Identifiers

PMID32670183
PMCPMC7330115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.